DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Winkelmann A, Loebermann M, Reisinger EC. et al.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Nat Rev Neurol 2016;
12: 217-233
We do not assume any responsibility for the contents of the web pages of other providers.